…stract 1-029 Figure 1Correlation of maximal wall thickness with NT-pro BNP in patients with pathogenic gene mutations for hypertrophic car…
4articles mentioning drugs
12drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: NT-pro BNP ×
NT-pro BNP
This drug is selected. Its supporting articles are shown below.
Articles mentioning NT-pro BNP
4 articles · page 1 of 1NT-pro BNPNT pro-BNPhypertrophic cardiomyopathyHCMhypertrophic cardiomyopathyAbstract
NT-pro BNPimmunosuppressive therapiesICI myocarditisImmune checkpoint inhibitor (ICI) myocarditis
…ar hs-cTnT levels as compared to patients without LGE (p=0.33). NT-pro BNP also had no significant correlations with native myocardial T1 …
98.2%
NT-pro BNPHeart FailureUniversity Hospital LimerickHFrEFHFUHL
… per patient, based on an estimated cost of €1,450 per bed day. NT-pro BNP levels decreased significantly from 10,598 ng/L at hospital adm…
MavacamtenValsalvaNT pro-BNPNT-pro BNPNICESix-Minute Walk Testhypertrophic cardiomyopathy
…ic therapies designed to target the underlying pathophysiology. Mavacamten, a first-in-class cardiac myosin inhibitor, received approval i…